2 курс / Нормальная физиология / Ликвор_как_гуморальная_среда_организма_Пикалюк_В_С_,_Бессалова_Е

440. Miyake A. Luteinizing hormone–releasing hormone in cerebrospinal fluid of women/ А. Miyake, Kurachi Н., Kawamurra J. // Endocr. Jap. – 1980. – Vol. 27, № 1. – P. 117–119.

441. Modulation of inflammation and immunity by cyclic AMP Receptors for vasoactive hormones and mediators of inflammation regulate many leukocyte functions / H.R. Bourne, L.M. Lichtenstein, K.L. Melmon et al. // Science. – 1974. – Vol. 184. – P. 19–28.

442. Molecular mechanisms of cerebrospinal fluid production / P. D. Brown, S. L. Davies, T. Speake et al. // Neuroscience. – 2004. – Vol. 129, 4. – P. 957–970.

443. MultiplicityКафедраof cerebrospinal fluid functions: new challenges in health and disease / C.E. Johanson, J.A. Duncan, P.M. Klinge et al. // Cerebrospinal fluid research. – 2008. – Vol. 5, 10. – P. 1 – 32.

444. Nathanson J.A. Immunological function of the blood– cerbrospinalнормальнойfluid barrier / Nathanson J.A., Chun L.Y. // Proc. Natl. Acad. Sci. USA. – 1989. – Vol. 86, № 3. – P. 1684–1688.

445. Negro M.F. Sur La fonction et L’aktion du liquide cephalo– nachidien / Negro M.F.// Revue Neurologigi. – 1931. – Vol. 11, № 6. –

446.NerenberyанатомииS.T. Cerebrospinal fluid Ig G, Ig A, Ig M, Ig D and Ig E. Levels in central nervous system disoders / S.Т. Nerenbery, R. Prasad, M.E. Kothman // Neurology. – 1978. – Vol.28, № 10. – P. 988–990.

447.NeuroendocrineКГМУmodulation of immune system / G. Dan, S.B. Lall // Indian Journal of Pharmacology. – 1998. – Vol. 30. – P.129–140.

448.Neuropeptide Y and corticotropin–releasing hormone in CSF mark response to antidepressive treatment with citalopram / G. Nikisch, H. Agren, C.B. Eap et al. // The International Journal of Neuropsychopharmacology. – 2005. – Vol. 8, № 3. – P. 403–410.

449.Ojeda S. Central effect of prostaglandin E1 (PGE1) on prolactin release / S. Ojeda, Р. Harnes, S. McConn // Endocrinology. – 1974. – Vol. 95, № 2. – P. 613–618

450.Ottaway C.A. Vasoactive intestinal peptide and immune function // Ottaway C.A. / Psychoneuroimmunology. –2 ed. – New York: Academic Press Inc., 1991. – P. 225–262.

451.Pardridge W.M. The blood–brain barrier: cellular and molecular biology/ Pardridge W.M.. –New York: Raven Press, 1993. – 430 p.

182ЛИКВОР КАК ГУМОРАЛЬНАЯ СРЕДА ОРГАНИЗМА

452.Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease / M.A. Raskind, E.R. Peskind, C. Holmes, D.S. Goldstein // Biol. Psychiatry. – 1999. – Vol. 46, № 6. – P. 756–765.

453.Pavel S. Presence of relative high concentrations of arginine vasotocin in the cerebrospinal fluid of newborns and infants / S. Pavel // J Clin. Endocr. – 1980. – Vol. 50, № 2. – P. 271–273.

454.Peptide repertoire of human cerebrospinal fluid: novel proteolytic fragments of neuroendocrine proteins / M. Stark, O.

Danielsson, W.J. Griffiths et al. // Journal of Chromatography B. – 2001.

– Vol. 754. –КафедраP. 357 –367.

455. Permeability of the blood–cerebrospinal fluid barrier to plasma proteins during fetal and perinatal life / А. Adinolfi, S.Е. Beck, S.A.

Haddad, M.H. Seller // Nature. – 1976. – Vol.259. – P. 140. 456нормальной. Plasma and cerebrospinal fluid amino acids in epileptic

patients / S. Rainesalo, T. Keranen, J. Palmio et al. // Neurochemical Research. – 2004. – Vol. 29, № 1. – Р. 319–324.

457.Plasma and cerebrospinal fluid concentration of neuropeptide Y, serotonin,анатомииand catechol–amines in patients under propofol or isoflurane anesthesia / E. Grouzmann, A. Borgeat, M. Fathi et al. // Can. J. Physiol. Pharmacol. – 2000. – Vol. 78, № 2. – P. 100–107.

458.Podell M. Cerebrospinal fluid gamma–aminobutyric acid and glutamate values КГМУin patients with epilepsy / М. Podell, Hadjiconstantinou М. // Am. J. Vet. Res. – 1997. – Vol. 58, № 5. – P. 451–456.

459.Porter J. Role of biogenic amines and cerebrospinal fluid in the neurovascular transmittal of hypophysotrophic substances / Porter J., Kamberi I., Ondo J. // Brain–Endocrine Interaction. –Basel, 1972. – P. 245–253.

460.Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica / H. Brisby, K. Olmarker, K. Larsson et al. // European Spine Journal. – 2002. – Vol. 11, № 1. – Р. 62–66.

461.Prolactin receptor on human lymphocytes and their modulation by cyclosporin / Russell D.H., Matrision L., R. Kibler R. et al. // Biochem Biophys Res Commun. – 1984. – Vol.121. – P. 899–906.

462.Pro–opiocortin peptides in rat Cerebrospinal fluid / S. Jackson, S. Kiser, R. Corder, P.J. Lowry // Regul Pept. – 1985. – Vol. 11, № 2. – P. 159–171.

463.Puri C.P. Bioactive luteinizing hormone in the plasma and cerebrospinal fluid of female rhesus monkeys / С.Р. Puri, Puri V., Anand Kumar Т.С. // J. Med. Primatol. – 1980. – Vol. 9, № 1 – 2. – P. 39–49.

464.Receptors for interleukin–1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus / E. Ban, G. Milon, N. Prudhomme et al. // Neuroscience. – 1991. – Vol. 43. – P. 21–30.

465.Richman D.P. Nicotinic acetylcholine receptor evidence for a functionally distinctКафедраreceptor on human lymphocytes / D.P. Richman, B.G. Arnason // Proc Natl Acad Sci USA. – 1979. – Vol. 76. – P. 4632–4635.

466.Riikonen R. Levels of cerebrospinal fluid nerve–growth factor

differ in infantile autism and Rett syndrome / R. Riikonen, R. Vanhala

3.– P.148нормальной– 152. Medicine and Child Neurology. – 1999. – Vol. 41, №

467.Rodriquez E. Morphological and functional relationships

between the hypothalamo–neurophisical system and cerebrospinal fluid / Е. Rodriquez //анатомииAspects of neuroendocrinology. V. Internat. Sympos. on neurosecretion. (eds. W. Bargman, B. Scharrer). – Berlin – N.Y., 1970.

– P. 352–365.

468.Rosler N. Intra vital lumbar and post mortem ventricular cerebrospinal fluid immunoreactiveКГМУinterleukin–6 in Alzheimer's disease patients / Rosler N., Wichart I., К.А. Jellinger // Acta Neurologica Scandinavica. – 2001. – Vol. 103, № 2. – P. 126–130.

469.Rossi S. Rapid quantification of the d–opioid receptor selective enkephalin DPDPE in canine cerebrospinal fluid by liquid chromatography–mass spectrometry / S. Rossi, Yaksh T. // Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. – 2002. – Vol. 772, № 1. – Р. 73–79.

470.Rother S. Filtration of liquor cerebrospinalis (CSF-filtration) technical concept and filter performance under in vitro conditions / Rother S., Knoblauch K.D., Kirschfink M.. //Neuropsychology. –1995. –Vol. 9. –Р. 82-85.

471.Sagen J. Adrenal Medullary Transplants Increase Spinal Cord Cerebrospinal Fluid Catecholamine Levels and Reduce Pain Sensitivity /

Sagen J., Kemmler J.E., Н. Wang // The Journal of Neurophysiology. – 2001. – Vol. 85, № 4. – Р. 1788-1792.

472. Samuel S. Compartmentation in amino acid transport across the blood brain barrier / S. Samuel, S. А. Schwartz // Neurochem res. – 1981. – Vol.6. – P. 755–759.

473. Sass J.O. Normal ascorbic acid in cerebrospinal fluid of patients with infantile neuronal ceroid–lipofuscinosis / Sass J.O., Skladal D., М. Brunner–Krainz // Metab Brain Dis. – 1999. – Vol. 14, № 1. – P. 67–70.

474. Scott D. The ventricular system in neuroendocrine mechanisms/КафедраScott D., Dudley G., К. Knigge // Cell and Tissue res. – 1974. – Vol. 154, № 1. – P. 1–16.

475. Scott Th. F. Pattern and concentration of Ig G in cerebrospinal

fluid in neurosarcoidosis / Scott Th. F., А.R. Seay A.R., Goust G.M. // Neurolнормальной. – 1989. – Vol.39. – P. 1637–1639.

476. Semenenia I.N. Changes in the prolactin content of the cerebrospinal fluid and blood serum in rabbits in dynamic hyperthermia

induced by Freund's complete adjuvant / Semenenia I.N., Gurin A.V. // Zh Evol BiokhimанатомииFiziol. – 1998. – Vol. 34, № 2. – P. 270–272.

477. Serial CSF corticotropin–releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder / D.G. Baker, S.A. West, W.E. Nicholson et al. // Am. J. Psychiatry. – 1999. –КГМУVol 156, № 4. – Р. 585–588.

478. Serotonin in cisternal cerebrospinal fluid of rhesus monkeys: basal levels and effects of sertraline administration / G.M. Anderson, A.J. Bennett, K.P. Weld et al. // Psychopharmacology. – 2002. – Vol. 161, № 1. – Р. 95–99.

479. Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers / A. Rousseau, S. Petren, J. Plannthin et al. // J. Neural. Transm. – 1999. – Vol. 106, № 9 – 10. – P. 883–888.

480. Sharief M.K. Intrathecal synthesis of Ig M in neurological diseases: a comparison between detection of oligoclonal bands and quantitative estimation / М.К. Sharief, Keir G., Thompson E.J. // J. Neurol. Sci. – 1990. – Vol. 96. – P. 131–142.

481.Shuller E. Central nervous system Ig G synthesis in multiple sclerosis. Application of a new formula / Shuller E., Sagar H.J. //Acta Neurol. Scand. – 1983. – Vol.67, № 6. – P. 365–371.

482.Simultaneous assay of prostaglandins and thromboxane in the cerebrospinal fluid by gas chromatography–mass spectrometry–selected ion monitoring / Т. Obata, Т. Nagakura, H. Maeda et al. // J. Chromatogr. В. Biomed. Sci. Appl. – 1999. – Vol. 731, № 1. – P. 73–81.

483.Skinner D.C. Does gonadotropin–releasing hormone in the cerebrospinal fluid modulate luteinizing hormone release / Skinner D.C.,

А. Caraty A., Evans N.P. // Neuro–endocrinology. – 1998. – Vol. 67, № 1. – P. 37–44. Кафедра

484. Speake T. Expression of aquaporin 1 and aquaporin 4 water channels in rat choroid plexus / T. Speake, L.J. Freeman, P.D. Brown //

Biochimica et Biophysica Acta. – 2003. – Vol. 1609. – P. 80 – 86. 485.нормальнойSpecific nonopiate receptor for beta endorphins / E. Hazum,

K.J. Chang, P. Cuatrecasas // Science. – 1979. – Vol. 205. – P. 1033– 1035.

486. Spinal–fluid lisozyme in the diagnosis of the central nervous system tumorsанатомии/ Newman I., А. Cacatian, Josephson A.S., А. Tsang A. // Lancet. – 1974. – P. 756.

487. Spontaneous central melatonin secretion and resorption kinetics of exogenous melatonin: a ventricular CSF study / O. M. Debus, A. Lerchl, H. W. BotheКГМУet al. // Journal of Pineal Research. – 2002. – Vol. 33, № 4. – Р. 213–217.

488. Sterba G. Cerbrospinal fluid and hormones / Sterba G. // Ependima and neurohormonal regulation: Proc. Internat. Symposium. – Bratislava., 1974. – P. 143–173.

489. Streptococcal meningitis effect of CSF filtration on inflammation and neuronal damage / Schmidt H., Stuertz К., Trostdorf F. et al. //J Neurol. –1999. –Vol. 246 . –Р. 1063–1068.

490. Stumpf W. Estrogen–neurons and . estrogen–neuron systems in the periventricular brain / Stumpf W. // Amer. J. Anat. – 1970. – Vol. 129, № 2. – P. 207–218.

491. Substance P recognition by a subset of human T lymphocyte / D. Payan, D. Brewster, A. Missirian–Bastian et al. // J. Clin. Invest. – 1984. – Vol. 74. – P. 1532–1539.

492. Suzuki T. Transient elevation of interleukin–6 levels at the initial stage of meningitis in children /Т. Suzuki, А. Ishiguro, Т. Shimbo // Clinical and Experimental Immunology. – 2003. – Vol. 131, № 3. – Р. 484–489.

493. Tabira T. Multiple sclerosis cerebrospinal fluid / Tabira T., Webster H. de F., S. Н. Wray S.H. // Neurocem. – 1976. – Vol. 59, № 1.

– Р. 1386 – 1390.

494. Tesch M. Liquorfiltration beim Stiff – Man – Syndrom / Tabira T., Webster H. de F., S.Н. Wray S.H. //Neurol Rehabil. – 1998.

– № 4. – Р. 80-82.

495. TheКафедраimpact of lumbar cerebrospinal fluid filtration on lumbar and ventricular CSF in pneumococcal meningitis / В. Pfausler, Stadlbaur

D., Herold M., Schmutzhard E. // Neurol Infect Epidemiol. – 1997. –

Vol.2. – Р. 173-175. 496нормальной. The involvement of the blood–brain and the blood–

cerebrospinal fluid barriers in the distribution of leptin into and out of the rat brain / D. Kurrimbux, Z. Gaffen, C.L. Farrell et al. //

Neuroscience. – 2004. – Vol. 123, № 2. – Р. 527–536.

497. Theанатомииpeptides of the immim –neuro–endocrine system /М.Aim //European J. Histochemistry. – 1993. – Vol. 7. – P. 10 – 12.

498. The role of monoamines in the control of gonado–tropin and prolactin secretion / S. McCann, Р. Kalra P., Donoso A., Bishop W. et al. // Brain–EndocrineКГМУInteraction. – Basel, 1972. – P. 224–235.

499. The some immunobiological properties of a cerebrospinal fluid: cytotoxic, cytolytic effects, use of a cerebrospinal fluid as a nutrient medium for the cultivation of cells and tissues / М.А. Kriventsov, Tkach V.V. (jr.), Bessalova Ye.Yu., Kiselev V.V. //

Таврический медико-биологический вестник (English Edition). – 2007. – Т. 10, № 3. – С. 257-259.

500. The syntax of immune–neuroendocrine communication / J.E. Blalock // Immunol Today. – 1994. – Vol. 15. – P. 504– 511.

501. Thompson E. Proteins of cerebrospinal fluid / E. Thompson. – Elsevier academic press, 2005. – 332 c.

502. Tortella F.C. Characterization of opioid peptide like anticonvul–sant activity in rat cerebrospinal fluid / Tortella F.C., Long J.B. // Brain Res. – 1988. – Vol. 456, № 1. – P. 139–146.

503.Tortella F.C. Endogenous anticonvulsant substance in cerebrospinal fluid in rats after generalized seizures / Tortella F.C., Long J.B. // Brain Res. – 1988. – Vol. 456, № 1. – P. 439–441.

504.Torzewski M. Integrated cytology of cerebrospinal fluid / M. Torzewski, K.J. Lackner, J. Bohl. – Springer–Verlag Berlin Heidelberg, 2008. – 93 p.

505.Unger H. The vasopressin and oxytocin content in the cerebrospinal fluid of rabbits under changed conditions / Н. Unger, Schwarzberg H., Schulz H // Ependima and neurohormonal regulation:

Proc. Internat. Symposium. – Bratislava., 1974. – P. 251–260.

506. UptakeКафедраof melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human

study / M.P. Van den Berg, P. Merkus, S.G. Romeijn et al. //

Pharmaceutical Research. – 2004. – Vol. 21, № 5. – Р. 799–802. 507.нормальнойUrwin S.C., Hunt P. Cerebrospinal fluid filtration in Guillain-

Barre syndrome / Urwin S.C., Hunt P. //Anaesthesia. –2000. – Vol. 55, № 5. –Р. 503-504.

– Vol. 36. – P. 595–610.

508. Van Duke H.B. Studying of cerebrospinal fluid / Н.В. Van Duke, Balley Ранатомии., Bucy Р.С. // Pharmakol. and Experim Therap. – 1929.

509. Vanhala R. Low levels of insulin–like growth factor–I in cerebrospinal fluid in children with autism / R. Vanhala, U. Turpeinen, R. Riikonen // DevelopmentalКГМУMedicine and Child Neurology. – 2001. – Vol. 43, № 9. – P.614 – 616.

510. Vascular endothelial growth factor and erythropoietin concentrations in cerebrospinal fluid of children with hydrocephalus / P. Koehne, F. Hochhaus, U. Felderhoff–Mueser et al. // Child's Nervous System. – 2002. – Vol. 18, № 3–4. – Р. 137–141.

511. Vascular endothelial growth factor in the cerebrospinal fluid of infants who died of sudden infant death syndrome: Evidence for antecedent hypoxia / J.L. Kimberly, H.F. Krous, J. Nadeau, B. Blackbourne // Pediatrics. – 2003. – Vol. 111, № 2. – Р. 358.

512. Wenkel H. Systemic immune deviation in the brain that does not depend on the integrity of the blood–brain barrier / H. Wenkel, J.W. Streilein, M.J. Young // The Journal of Immunology. – 2000. – Vol. 164.

– P. 5125–5131.

188ЛИКВОР КАК ГУМОРАЛЬНАЯ СРЕДА ОРГАНИЗМА

513.Wieser H.G. Rasmussen’s encephalitis new treatment strategies / Wieser H.G. // The Third YONSEI Epilepsy Symposium. – Seoul , 1996.

514.Wildt L. Hypothalamus. Reproductionsmedizin / Wildt L. // Ed Hrsg. Von Bettendorf G, Breckwoldt M. –Stuttgart: Fischer,1989. – P. 6–22.

515.Woo A.H.–T. Brain–immune system interactions: analysis of immunoglobulin A in cerebrospinal fluid / A.H.–T. Woo //Dissertation Abstracts International. – 1992. – Vol. 52, № 9. – P. 4662.

516.Wybran J. Interrelations between the immune system and the central nervousКафедраsystem: physiological, and pathological consequences / Wybran J. // Acta Clin. Belg. – 1984. – Vol. 39, № 3. – P. 131–135.

517.Wybran J. Neuroimmunoendocrinology / Wybran J. //

Immunology today. – 1989. – Vol. 10, № 9. – P. 319–325. 518нормальной. Zhao W.G. Сerebrospinal fluid Ig G, Ig A, Ig m, Ig D and Ig E

levels in healthy individuals with related parameters analysis / Zhao W.G.,Yu Y.C., Li Y.D. // J. Neuroimmunol. – 1987. – Vol.16, № 1. – P.

194.

of trigemino–hypoglossal reflex in rats / Zubrzycka M., Janecka А. //

519. ZubrzyckaанатомииM. Substance P content in the cerebrospinal fluid and fluid perfusing cerebral ventricles during elicitation and inhibition

Brain Research. – 2002. – Vo l. 941, № 1–2. – Р. 29–33.

КГМУ

189

Для заметок

Кафедра

нормальной

анатомии

КГМУ

190

СОДЕРЖАНИЕ

Часть 2. БИОЛОГИЧЕСКИЕ СВОЙСТВА И ТЕРАПЕВТИЧЕСКОЕ ПРИМЕНЕНИЕ СПИННОМОЗГОВОЙ